Vital is a podcast by Polígrafo and Viral, in partnership with the Champalimaud Foundation.

This episode was hosted by journalist Marta Sofia Ribeiro.

The Champalimaud Foundation is in no way responsible for the data, information or viewpoints expressed within the context of the project, nor is it bound by them. Responsibility for these, under applicable law, lies solely with the authors, the interviewees, the editors or the distributors of the initiative.

Vital is a podcast by Polígrafo and Viral, in partnership with the Champalimaud Foundation.

This episode was hosted by journalist Marta Sofia Ribeiro.

The Champalimaud Foundation is in no way responsible for the data, information or viewpoints expressed within the context of the project, nor is it bound by them. Responsibility for these, under applicable law, lies solely with the authors, the interviewees, the editors or the distributors of the initiative.

Vital is a podcast by Polígrafo and Viral, in partnership with the Champalimaud Foundation.

This episode was hosted by journalist Sara Beatriz Monteiro.

The Champalimaud Foundation is in no way responsible for the data, information or viewpoints expressed within the context of the project, nor is it bound by them. Responsibility for these, under applicable law, lies solely with the authors, the interviewees, the editors or the distributors of the initiative.
 

The initiative aims to strengthen health literacy through accessible, educational content based on the best available scientific evidence.

Developed through a partnership between the Champalimaud Foundation and the Faculdade de Medicina da Universidade de Lisboa (FMUL), the programme supports the career development of surgeons and clinician-scientists committed to advancing cancer research. The PhD degree is granted by FMUL within the framework of the Lisbon Academic Medical Centre PhD Programme.

A study just published in the prestigious Journal of Clinical Oncology definitively establishes the introduction of low-dose Tamoxifen into clinical practice as post-surgical therapy for the prevention of ductal carcinoma in situ (DCIS), the initial non-invasive form that accounts for around 25% of all breast cancers diagnosed through mammographic screening.

The Open Labs are where scientific research comes to life at the Champalimaud Foundation.

Filled every day with scientists discussing ideas, testing setups, analysing data and challenging assumptions, these spaces thrive on curiosity, collaboration and discovery.

Here, questions are encouraged. Experiments are tested, sometimes fail, and are then rethought, refined and repeated, transforming uncertainty into knowledge.

With a career spanning leadership of some of Europe’s most influential biomedical research institutions, Otmar Wiestler joins the Champalimaud Foundation as Director of Champalimaud Science. An internationally recognised physician-scientist and research leader, he has played a central role in shaping large-scale scientific organisations, most notably as President of the Helmholtz Association and, prior to that, as Chairman and CEO of the German Cancer Research Center (DKFZ).

For millions of Portuguese people, a cup of coffee is a daily ritual. Can this deeply ingrained habit play a role in the prevention, treatment or survival of breast cancer? 

The agreement between the two organisations will enable the reinforcement of the Breast Cancer Research Program (BCRP) from the Breast Department to launch a pioneering line of research in Portugal. This line of research is entirely funded by Delta Cafés, which is thus playing an active role in advancing scientific knowledge.

The Vision Award Office is where ideas are shaped into global recognition.

It is here that the António Champalimaud Vision Award takes form, through careful preparation, collaboration and informed decision-making.

It is also home to the Ethics Committee, where research projects, in particular clinical studies, are supported and rigorously reviewed.

Here, decisions are not rushed. They are considered, debated and refined.

Because creating impact, and recognising it, requires the freedom to think deeply, to question, and to choose with responsibility.